Results 251 to 260 of about 2,075,479 (379)

Activation of HTR2B Suppresses Osteosarcoma Progression through the STAT1‐NLRP3 Inflammasome Pathway and Promotes OASL1+ Macrophage Production to Enhance Antitumor Immunity

open access: yesAdvanced Science, EarlyView.
Activation of HTR2B suppresses osteosarcoma progression through the STAT1‐NLRP3 inflammasome pathway and promotes OASL1+ Macrophage production to enhance anti‐tumor immunity. Abstract Osteosarcoma is a primary malignant bone tumor originating from mesenchymal tissue, and associated with poor prognosis.
Zhen Huang   +7 more
wiley   +1 more source

Prognostic value of absolute lymphocyte count in oral cavity squamous cell carcinoma. [PDF]

open access: yesLaryngoscope Investig Otolaryngol, 2023
Shah R, Liu C, Shah HP, Judson BL.
europepmc   +1 more source

Protease inhibitor-resistant HIV-1 from patients with preserved CD4 cell counts is cytopathic in activated CD4 T lymphocytes

open access: bronze, 2001
Teri Liegler   +5 more
openalex   +1 more source

Nicotine Reprograms Aging‐Related Metabolism and Protects Against Motor Decline in Mice

open access: yesAdvanced Science, EarlyView.
Long‐term oral nicotine intake protects against age‐related motor decline in mice without eliciting systemic toxicity. Integrated multi‐organ metabolomic profiling and longitudinal gut microbiota analyses reveal that nicotine induces coordinated remodeling of glycolipid and sphingolipid metabolism, enhances NAD⁺ bioavailability, and suppresses ceramide
Shuhui Jia   +29 more
wiley   +1 more source

Low leucocyte, neutrophil and lymphocyte count (tri-low phenotype) in melioidosis: A predictor of early mortality. [PDF]

open access: yesCurr Res Microb Sci
Gupta N   +7 more
europepmc   +1 more source

Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load [PDF]

open access: hybrid, 2004
Laurent Humeau   +13 more
openalex   +1 more source

Home - About - Disclaimer - Privacy